About Us  |  Contact Us
Woman And Infants
Women's Choice Award 2015
Woman And Infants

Chemo combinations for ovarian or fallopian tube cancer

Organizations Women & Infants
Research Type Clinical
Therapeutic Area of Study Cancer - Ovarian
Recruitment Status Open
Date Recruitment Ends 02/12/2013
Date Study Started 02/13/2012
Date Study Ends 02/12/2013
Contact Information

(401) 274-1122, ext. 8181


A GCIG intergroup multicenter phase III trial of open label Carboplatin and Paclitaxel +/- NCI supplied agent: Bevacizumab (NSC# 704865, IND#7921) compared with Oxaliplatin and Capecitabine +/- Bevacizumab as first line chemotherapy in patients with mucinous epithelial ovarian or fallopian tube cancer (MEOC)

Look for another study
Care New England
© 2015 Site Index | Disclaimer | Legal Notices | Talks Your Health